Inventors list
Assignees list
Classification tree browser
Top 100 Inventors
Top 100 Assignees
43rd week of 2020 patent applcation highlights part 10
Patent application number
Title
Published
20200330527
GANGLIOSIDE GM3-CONTAINING NANOPARTICLES AS IMMUNOMODULATORS
2020-10-22
20200330528
SPORE-BASED PROBIOTIC COMPOSITION FOR MODULATION OF DERMAL AND SUB-DERMAL PROPERTIES
2020-10-22
20200330529
Microbiome-based informed method to formulate live biotherapeutics
2020-10-22
20200330530
HEPATOPROTECTION FOOD COMPOSITION AND PHARMACEUTICAL COMPOSITION WITH STRAINS OF LACTIC ACID BACTERIA
2020-10-22
20200330531
PROBIOTICS FOR COGNITIVE AND MENTAL HEALTH
2020-10-22
20200330532
MICROORGANISM HAVING ABILITY TO DEGRADE ETHANOL AND ACETALDEHYDE, AND COMPOSITION AND KIT EACH INCLUDING THE SAME
2020-10-22
20200330533
BIOMARKERS AND COMBINATION THERAPIES USING ONCOLYTIC VIRUS AND IMMUNOMODULATION
2020-10-22
20200330534
EXPRESSION OF METABOLIC MODULATORS IN TUMOR MICROENVIRONMENT TO IMPROVE TUMOR THERAPY
2020-10-22
20200330535
NUTRITIONAL SUPPORT FOR ANIMALS VIA ADMINISTRATION OF AN ALGAL DERIVED SUPPLEMENT
2020-10-22
20200330536
SUPPLEMENT FOR MENOPAUSE
2020-10-22
20200330537
TOBACCO PRODUCTS WITH CANNABINOID ADDITIVES AND METHODS FOR REDUCING THE HARM ASSOCIATED WITH TOBACCO USE
2020-10-22
20200330538
NOVEL USE OF COMBINATION OR COMPOSITION OF PANAX NOTOGINSENG AND ASPIRIN
2020-10-22
20200330539
COMPOSITIONS CONTAINING SILYMARIN AND SULFOALKYL ETHER CYCLODEXTRIN AND METHODS OF USING THE SAME
2020-10-22
20200330540
PHARMACEUTICAL COMPOSITIONS COMPRISING PLANT EXTRACTS AND METHODS FOR REDUCING DURATION OF A COMMON COLD USING SAME
2020-10-22
20200330541
COMPOSITIONS AND METHODS FOR MODULATING ENDOTHELIAL CELL MIGRATION AND ANGIOGENESIS
2020-10-22
20200330542
COMPOSITION FOR THE ACUTE AND CHRONIC TREATMENT OF CONSTIPATION
2020-10-22
20200330543
A topical herbal healing formulation
2020-10-22
20200330544
COMPOSITIONS FOR IMPROVING LEAN BODY MASS, BROWN ADIPOSE TISSUE AND FOR INHIBITING ADVANCED GLYCATION ENDS PRODUCT
2020-10-22
20200330545
PHARMACEUTICAL COMBINATION COMPRISING AN IBAT INHIBITOR AND A BILE ACID BINDER
2020-10-22
20200330546
HANGOVER ALLEVIATING COMPOSITION CONTAINING CONJUGATE OF SESAMOL AND PEPTIDE AS ACTIVE INGREDIENT
2020-10-22
20200330547
Method of Treating a Child with Central Precocious Puberty using an Extended Release Composition
2020-10-22
20200330549
CYTOCIDAL AGENT
2020-10-22
20200330550
METHOD FOR MODULATING INSULIN-INDEPENDENT GLUCOSE TRANSPORT USING TENEURIN C-TERMINAL ASSOCIATED PEPTIDE (TCAP)
2020-10-22
20200330551
COMPOSITIONS AND METHODS OF TREATING CANCER USING LIPID AGONISTS AND RECEPTORS THEREOF
2020-10-22
20200330552
NOVEL IMMUNOTHERAPY AGAINST SEVERAL TUMORS INCLUDING GASTROINTESTINAL AND GASTRIC CANCER
2020-10-22
20200330553
MATERIALS AND METHODS FOR EXTRACELLULAR VESSICLE-ASSOCIATED DISEASES
2020-10-22
20200330554
GLYCOPROTEINS HAVING LIPID MOBILIZING PROPERTIES AND THERAPEUTIC USES THEREOF
2020-10-22
20200330555
METHODS OF TREATING GASTROINTESTINAL MOTILITY-RELATED DISORDERS USING VARIANTS AND FUSIONS OF FGF19/FGF21 POLYPEPTIDES
2020-10-22
20200330556
Methods for Administering STING Agonists
2020-10-22
20200330557
USES OF PD-1/PD-L1 INHIBITORS AND/OR CTLA-4 INHIBITORS WITH A BIOLOGIC CONTAINING MULTIPLE CYTOKINE COMPONENTS TO TREAT CANCER
2020-10-22
20200330558
METHODS OF USING AND COMPOSITIONS CONTAINING DULAGLUTIDE
2020-10-22
20200330560
LIPID-BASED NANOPARTICLES AND METHODS USING SAME
2020-10-22
20200330561
COMPOSITION FOR TREATMENT OF FACIAL NERVE PALSY
2020-10-22
20200330562
PATCH LOADED WITH DUAL-SENSITIVE VESICLES FOR ENHANCED GLUCOSE-RESPONSIVE INSULIN DELIVERY
2020-10-22
20200330563
BOTULINUM NEUROTOXIN A SUBTYPE 6 AND PHARMACOLOGICAL METHODS OF USE
2020-10-22
20200330564
METHOD TO MANUFACTURE A STABLE PROTEIN
2020-10-22
20200330565
METHODS AND COMPOSITIONS FOR PRE-EMPTIVE TREATMENT OF GRAFT VERSUS HOST DISEASE
2020-10-22
20200330566
Cancer Stem Cell-Targeted Cancer Therapy
2020-10-22
20200330567
Radiohalogenated Agents for in Situ Immune Modulated Cancer Vaccination
2020-10-22
20200330568
NEOSPORA FOR USE IN TREATING CANCER AND INFECTIOUS DISEASES
2020-10-22
20200330569
Peptide Conjugated Particles
2020-10-22
20200330570
PEPTIDE AND METHOD FOR REDUCING THE PHOSPHATE REQUIREMENT AND EXCRETION FROM FARM ANIMALS
2020-10-22
20200330571
FORMULATIONS FOR NEOPLASIA VACCINES
2020-10-22
20200330572
BCMA CHIMERIC ANTIGEN RECEPTORS
2020-10-22
20200330573
BACTERIOLOGICALLY-MODIFIED WHOLE-CELL TUMOR VACCINE AND METHOD OF MAKING SAME
2020-10-22
20200330574
IL-36 SECRETING IMMUNORESPONSIVE CELLS AND USES THEREOF
2020-10-22
20200330575
EFFECTIVE AND EFFICIENT CONTROL OF SERUM PHOSPHATE FOR OPTIMAL BONE FORMATION
2020-10-22
20200330576
ALDH1 ANTIGEN-PULSED DENDRITIC CELLS
2020-10-22
20200330577
MYCOPLASMA HYOPNEUMONIAE VACCINE
2020-10-22
20200330578
PNEUMOCOCCAL POLYSACCHARIDES AND THEIR USE IN IMMUNOGENIC POLYSACCHARIDE-CARRIER PROTEIN CONJUGATES
2020-10-22
20200330579
SACCHARIDE-POLYPEPTIDE CONJUGATE COMPOSITIONS AND METHODS OF USE THEREOF
2020-10-22
20200330580
Transcutaneous Dosage Formulation
2020-10-22
20200330581
ONCOLYTIC CANCER IMMUNOTHERAPIES AND METHODS OF USE
2020-10-22
20200330582
CANCER TREATMENT UTILIZING PRE-EXISTING MICROBIAL IMMUNITY
2020-10-22
20200330583
MODIFIED NOROVIRUS VP1 PROTEINS AND VLPS COMPRISING MODIFIED NOROVIRUS VP1 PROTEINS
2020-10-22
20200330584
COMPUTATIONALLY OPTIMIZED BROADLY REACTIVE ANTIGENS FOR INFLUENZA
2020-10-22
20200330585
SWINE INFLUENZA A VIRUS VACCINE
2020-10-22
20200330586
A VACCINE FOR USE IN THE PROPHYLAXIS AND/OR TREATMENT OF A DISEASE
2020-10-22
20200330587
EPSTEIN-BARR VIRUS VACCINES
2020-10-22
20200330588
BROADLY NEUTRALIZING ANTI-HUMAN CYTOMEGALOVIRUS (HCMV) ANTIBODIES AND METHODS OF USE THEREOF
2020-10-22
20200330589
MILK-BASED PROTEIN HYDROLYSATES AND INFANT FORMULAE AND NUTRITIONAL COMPOSITIONS MADE THEREOF
2020-10-22
20200330590
METHODS AND COMPOSITIONS FOR REDUCTION OF IMMUNOGENICITY
2020-10-22
20200330591
TREATMENT
2020-10-22
20200330592
COMPOSITIONS AND METHODS OF TREATING ALZHEIMER'S AND OTHER AMYLOID RELATED DISEASES
2020-10-22
20200330593
Clinically Proven Subcutaneous Pharmaceutical Compositions Comprising Anti-CD38 Antibodies and Their Uses in Combination with Bortezomib, Mephalan and Prednisone
2020-10-22
20200330594
Combination Therapies Comprising Daratumumab, Bortezomib, Thalidomide and Dexamethasone and Their Uses
2020-10-22
20200330595
PD-1 RELATED CANCER THERAPY
2020-10-22
20200330596
ALLOGENIC TUMOR CELL VACCINE
2020-10-22
20200330597
ANTI-GLUCOSAMINIDASE PASSIVE IMMUNIZATION FOR STAPHYLOCOCCUS AUREUS INFECTIONS
2020-10-22
20200330598
Nanoparticles for Cancer Therapy and Diagnosis
2020-10-22
20200330599
Liposomal System for Drug Delivery
2020-10-22
20200330600
PHARMACEUTICAL COMPOSITION
2020-10-22
20200330601
IL-2 Conjugates and Methods of Use Thereof
2020-10-22
20200330602
METHOD FOR IMPROVING THE ORAL BIOAVAILABILITY OF A DRUG
2020-10-22
20200330603
PEPTIDES FOR RENAL THERAPY
2020-10-22
20200330604
PREPARATION OF MAYTANSINOID ANTIBODY CONJUGATES BY A ONE-STEP PROCESS
2020-10-22
20200330605
ANTI-TUMOUR IMMUNE RESPONSES TO MODIFIED SELF-EPITOPES
2020-10-22
20200330606
MODULATION OF STRUCTURAL MAINTENANCE OF CHROMOSOME-1 EXPRESSION
2020-10-22
20200330607
Multiplexed Analysis of Materials for Tissue Delivery
2020-10-22
20200330608
GENE THERAPY FOR EOSINOPHILIC DISORDERS
2020-10-22
20200330609
MATERIALS AND METHODS FOR TREATMENT OF HEMOGLOBINOPATHIES
2020-10-22
20200330610
COMPOSITIONS AND METHODS FOR ENHANCED FLUORESCENCE
2020-10-22
20200330611
METHODOLOGY FOR IDENTIFYING GENE DELIVERY VECTORS WITH RETINAL CELL SPECIFICITY IN NON-HUMAN PRIMATE
2020-10-22
20200330612
MOLECULAR PROBES FOR DETECTION AND IMAGING OF PANCREATIC CANCER
2020-10-22
20200330613
SALICYLIC ACID-BASED POLYMERIC CEST CONTRAST AGENTS TARGETING PROSTATE-SPECIFIC MEMBRANE ANTIGEN AND USES THEREOF
2020-10-22
20200330614
Imaging Neurotransmitters In Vivo Using Functionalized Carbon Nanotubes
2020-10-22
20200330615
NONINVASIVE IMAGING OF FOCAL ATHEROSCLEROTIC LESIONS USING FLUORESCENCE MOLECULAR TOMOGRAPHY
2020-10-22
20200330616
BIOMIMETIC NON-IMMUNOGENIC NANOASSEMBLY FOR THE ANTITUMOR THERAPY
2020-10-22
20200330617
NANOPARTICLE, CONTRAST AGENT FOR MAGNETIC RESONANCE IMAGING CONTAINING SAME, AND LIGAND COMPOUND
2020-10-22
20200330618
PREPARATION FOR MAGNETIC RESONANCE DIAGNOSTICS FOR ONCOLOGICAL DISEASES, COMPRISING DEUTERATED 3-O-METHYLGLUCOSE, AND DIAGNOSTIC METHOD USING SAID PREPARATION
2020-10-22
20200330619
IMAGING PHANTOM
2020-10-22
20200330620
TARGETED GAS-FILLED MICROVESICLES FORMULATION
2020-10-22
20200330621
Targeted Radiotherapy Chelates for In Situ Immune Modulated Cancer Vaccination
2020-10-22
20200330622
USE OF BERBERINE OR DERIVATIVE THEREOF IN PREPARING MYOCARDIAL PERFUSION IMAGING AGENT
2020-10-22
20200330623
MULTINUCLEAR COMPLEXES AND THEIR PREPARATION
2020-10-22
20200330624
IMAGING AND RADIOTHERAPEUTICS AGENTS TARGETING FIBROBLAST-ACTIVATION PROTEIN-ALPHA (FAP-ALPHA)
2020-10-22
20200330625
SYNTHESIS AND COMPOSITION OF PHOTODYNAMIC THERAPEUTIC AGENTS FOR THE TARGETED TREATMENT OF CANCER
2020-10-22
20200330626
FLUORINE-18 LABELED COMPOSITIONS AND THEIR USE IN IMAGING OF BIOLOGICAL TISSUE
2020-10-22
20200330627
APPARATUS FOR STERILISING ROOT CANAL FILLING MATERIAL WITH UV LIGHT
2020-10-22
20200330628
SYSTEMS AND METHODS FOR PHOTOACTIVATION OF A BIOLOGICAL FLUID
2020-10-22